Clinical trials increasingly rely on endpoint adjudication to better assess patient events and
provide standardised endpoint classifications. The increased trend toward the use of endpoint adjudication in a wider variety of clinical trials is being driven by regulatory, clinical, business and technology trends:

Available Downloads

Related Intelligence and Suppliers

eClinicalOS™ (eCOS)
eClinicalOS™ (eCOS) from Merge eClinical is a single, scalable cloud-based platform that lets clinical research professionals design, launch and manage studies with more control, convenience and confidence than ever before. With headquarters in Research Triangle Park, N.C., and offices around the globe, Merge eClinical serves researchers in all industry categories: pharmaceutical and device manufacturers, CROs and academic institutions. Through active sites in 80-plus countries, more than 50,000 clinical research professionals in small and large organizations have entrusted their data and study management needs to our flagship product, eCOS.
Products